Ralf Lutterbuese
Impact in
- Oncology top 5%
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 9
- Radiopharmaceutical Chemistry and Applications 1
- Oncology 9
- CAR-T cell therapy research 7
- Colorectal Cancer Treatments and Studies 1
- Cancer Cells and Metastasis 1
- Co-authors
- Peter Kufer (10 shared papers)Patrick Alexander Baeuerle (10 shared papers)Bernd Schlereth (7 shared papers)Tobias Raum (5 shared papers)Klaus Brischwein (5 shared papers)Roman Kischel (6 shared papers)Grit Lorenczewski (5 shared papers)Doris Rau (4 shared papers)
- Journals
- Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of Immunotherapy (2 papers)Molecular Immunology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanySwitzerland
In The Last Decade
Ralf Lutterbuese
11 papers receiving 1.6k citations
Ralf Lutterbuese's Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 1.0k
- Radiology, Nuclear Medicine and Imaging 686
- Immunology 530
- Hematology 267
- Public Health, Environmental and Occupational Health 393
Countries citing papers authored by Ralf Lutterbuese
This map shows the geographic impact of Ralf Lutterbuese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lutterbuese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lutterbuese more than expected).
Fields of papers citing papers by Ralf Lutterbuese
This network shows the impact of papers produced by Ralf Lutterbuese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lutterbuese. The network helps show where Ralf Lutterbuese may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Lutterbuese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival Hit paper breakdown → | 2011 | 780 |
| 2 | 2005 | 222 | |
| 3 | 2010 | 138 | |
| 4 | 2012 | 124 | |
| 5 | 2005 | 106 | |
| 6 | 2008 | 73 | |
| 7 | 2007 | 70 | |
| 8 | 2009 | 67 | |
| 9 | 2008 | 65 | |
| 10 | 2009 | 48 | |
| 11 | Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3 | 2007 | 3 |
About Ralf Lutterbuese
Ralf Lutterbuese is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Cellular and Molecular Neuroscience and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper), RNA Interference and Gene Delivery (1 paper), Cancer Cells and Metastasis (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (686 citations), Immunology (530 citations), Hematology (267 citations) and Public Health, Environmental and Occupational Health (393 citations). Ralf Lutterbuese has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Peter Kufer, Patrick Alexander Baeuerle, Bernd Schlereth, Tobias Raum, Klaus Brischwein, Roman Kischel, Grit Lorenczewski, Doris Rau, Thomas Urbig and Andreas Wolf. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Immunotherapy, Molecular Immunology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.